DK1121135T3 - Præparater af beta-glucaner og specifikke immunglobuliner - Google Patents

Præparater af beta-glucaner og specifikke immunglobuliner

Info

Publication number: DK1121135T3
Authority: DK; Denmark
Prior art keywords: beta; glucans; preparations; specific immunoglobulins; kits
Prior art date: 1998-09-14

Application number

DK99969030T

Other languages

Danish (da)

English (en)

Inventor

Viliam Pavliak

Ali Ibrahim Fattom

Robert B Naso

Original Assignee

Nabi Biopharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-14

Filing date

1999-09-14

Publication date

2009-03-23

1999-09-14 Application filed by Nabi Biopharmaceuticals filed Critical Nabi Biopharmaceuticals

2009-03-23 Application granted granted Critical

2009-03-23 Publication of DK1121135T3 publication Critical patent/DK1121135T3/da

Links

229920002498 Beta-glucan Polymers 0.000 title abstract 3
229940043517 specific immunoglobulins Drugs 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title 1
244000000010 microbial pathogen Species 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Public Health (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK99969030T 1998-09-14 1999-09-14 Præparater af beta-glucaner og specifikke immunglobuliner DK1121135T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10014698P	1998-09-14	1998-09-14
PCT/US1999/020787 WO2000015238A1 (en)	1998-09-14	1999-09-14	COMPOSITIONS OF β-GLUCANS AND SPECIFIC IGIV

Publications (1)

Publication Number	Publication Date
DK1121135T3 true DK1121135T3 (da)	2009-03-23

Family

ID=22278313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99969030T DK1121135T3 (da)	1998-09-14	1999-09-14	Præparater af beta-glucaner og specifikke immunglobuliner

Country Status (11)

Country	Link
US (1)	US6355625B1 (es)
EP (1)	EP1121135B1 (es)
AT (1)	ATE421883T1 (es)
AU (1)	AU6033299A (es)
CA (1)	CA2344166C (es)
CY (1)	CY1109437T1 (es)
DE (1)	DE69940371D1 (es)
DK (1)	DK1121135T3 (es)
ES (1)	ES2321892T3 (es)
PT (1)	PT1121135E (es)
WO (1)	WO2000015238A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6610293B1 (en) *	1997-06-16	2003-08-26	The Henry M. Jackson Foundation For The Advancement Of Military Medicine	Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6756361B1 (en) *	1997-10-14	2004-06-29	Nabi	Enterococcus antigens and vaccines
US7030101B2 (en) *	1998-09-14	2006-04-18	Nabi Biopharmaceuticals	Compositions of β-glucans and specific antibodies
US6936258B1 (en) *	1999-03-19	2005-08-30	Nabi Biopharmaceuticals	Staphylococcus antigen and vaccine
US7507724B2 (en)	2001-01-16	2009-03-24	Sloan-Kettering Institute For Cancer Research	Therapy-enhancing glucan
EP1357919B1 (en) *	2001-01-16	2017-04-05	Sloan-Kettering Institute For Cancer Research	Therapy-enhancing glucan
US7786094B2 (en) *	2001-10-09	2010-08-31	Biopolymer Engineering, Inc.	Use of beta-glucans against biological warfare weapons and pathogens including anthrax
US8883760B2 (en) *	2002-09-04	2014-11-11	University Of Louisville Research Foundation, Inc.	Cancer therapy using beta glucan and antibodies
US20060165700A1 (en) *	2002-09-04	2006-07-27	Ostroff Gary R	Cancer therapy using whole glucan particles and antibodies
CN1964722A (zh) *	2004-05-10	2007-05-16	生物聚合物工程有限公司	与抗生素、疫苗和病毒单克隆抗体组合的全葡聚糖颗粒
NZ553776A (en)	2004-09-22	2010-05-28	Glaxosmithkline Biolog Sa	Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
US20060134141A1 (en) *	2004-12-14	2006-06-22	Nabi Biopharmaceuticals	Glycoconjugate vaccines containing peptidoglycan
WO2006076058A1 (en) *	2005-01-10	2006-07-20	Nabi Biopharmaceuticals	Method of treating staphylococcus aureus infection
US20060228368A1 (en) *	2005-04-07	2006-10-12	Nabi Biopharmaceuticals	Method of protecting against staphylococcal infection
US20070059310A1 (en) *	2005-05-03	2007-03-15	Karel Steven J	Therapeutic combination compositions and methods of using same
MX2007013725A (es) *	2005-05-05	2008-04-09	Sensient Flavors Inc	Produccion de beta-glucanos y mananos.
TWI374892B (en)	2005-06-13	2012-10-21	Glaxosmithkline Biolog Sa	Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
GB0526038D0 (en)	2005-12-21	2006-02-01	Glaxosmithkline Biolog Sa	Immunogenic composition
US8323644B2 (en)	2006-01-17	2012-12-04	Sloan-Kettering Institute For Cancer Research	Therapy-enhancing glucan
EP2476433A1 (en)	2006-03-30	2012-07-18	GlaxoSmithKline Biologicals S.A.	Immunogenic composition
US20080131457A1 (en)	2006-06-12	2008-06-05	Nabi Biopharmaceuticals	Use of alpha-toxin for treating and preventing staphylococcus infections
EP2208787A1 (en)	2009-01-19	2010-07-21	Université de Liège	A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
WO2010085590A1 (en)	2009-01-23	2010-07-29	Biosynexus Incorporated	Opsonic and protective antibodies specific for lipoteichoic acid gram positive bacteria
HUE026855T2 (en)	2009-04-03	2016-07-28	Univ Chicago	Compositions and methods related to protein a (spa) variants
GB0913680D0 (en)	2009-08-05	2009-09-16	Glaxosmithkline Biolog Sa	Immunogenic composition
GB0913681D0 (en)	2009-08-05	2009-09-16	Glaxosmithkline Biolog Sa	Immunogenic composition
EP2555794A4 (en)	2010-04-05	2014-01-15	Univ Chicago	COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
EP4015523A1 (en)	2010-05-05	2022-06-22	New York University	Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
CA2803298C (en)	2010-07-02	2020-07-14	The University Of Chicago	Compositions and methods related to protein a (spa) variants
EP2614074A1 (en)	2010-09-09	2013-07-17	The University of Chicago	Methods and compositions involving protective staphylococcal antigens
US8945588B2 (en)	2011-05-06	2015-02-03	The University Of Chicago	Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US8846609B2 (en)	2011-06-19	2014-09-30	New York University	Leukotoxin E/D as a new anti-inflammatory agent and microbicide
NZ764564A (en)	2011-06-19	2022-10-28	Univ New York	Methods of treating and preventing staphylococcus aureus infections and associated conditions
BR112014003315A2 (pt)	2011-08-15	2017-03-01	Univ Chicago	composições e métodos relacionados a anticorpos para a proteína a estafilocócica
JP6670106B2 (ja)	2012-04-26	2020-03-18	ザ・ユニバーシティ・オブ・シカゴＴｈｅＵｎｉｖｅｒｓｉｔｙＯｆＣｈｉｃａｇｏ	ブドウ球菌コアグラーゼ抗原およびその使用方法
CN104703622B (zh)	2012-04-26	2017-05-24	芝加哥大学	与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
EP3363462A1 (en)	2012-04-30	2018-08-22	Biothera, Inc.	Compositions and methods for beta-glucan immunotherapy
GB201310008D0 (en)	2013-06-05	2013-07-17	Glaxosmithkline Biolog Sa	Immunogenic composition for use in therapy
AU2015359503B2 (en)	2014-12-10	2019-05-09	Glaxosmithkline Biologicals Sa	Method of treatment
AU2017218768B2 (en)	2016-02-12	2022-03-31	Janssen Pharmaceuticals, Inc.	Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
WO2018156888A1 (en)	2017-02-24	2018-08-30	Biothera Pharmaceuticals, Inc.	Beta glucan immunopharmacodynamics
US12514914B2 (en)	2019-05-14	2026-01-06	The University Of Chicago	Methods and compositions comprising Staphylococcus protein a (SpA) variants
WO2020256795A1 (en)	2019-06-19	2020-12-24	The Research Foundation For The State University Of New York	Methods for treating neointimal hyperplasia using f11r/jam-a inhibitors
CN114929750B (zh)	2019-09-13	2024-11-22	芝加哥大学	用于治疗葡萄球菌感染的方法和组合物
JP2022550884A (ja)	2019-10-02	2022-12-05	ヤンセンファッシンズアンドプリベンションベーフェー	スタフィロコッカス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）ペプチドおよび使用方法
WO2023192998A1 (en)	2022-04-01	2023-10-05	Icahn School Of Medicine At Mount Sinai	Treating orthopedic injury with a vector driving expression of acid ceramidase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4900722A (en) *	1985-08-19	1990-02-13	Bioglucans, L.P.	Methods and compositions for prophylactic and therapeutic treatment of infections
US4739046A (en) *	1985-08-19	1988-04-19	Luzio Nicholas R Di	Soluble phosphorylated glucan
US5032401A (en) *	1989-06-15	1991-07-16	Alpha Beta Technology	Glucan drug delivery system and adjuvant
CA2040374C (en) *	1990-07-06	1998-06-16	Gunnar Rorstad	Process for enhancing the resistance of aquatic animals to disease
ES2198405T3 (es) *	1991-11-22	2004-02-01	Nabi Biopharmaceuticals	Antigenos de superficie de tipo i asociados a staphylococcus epidermis.
WO1996014873A2 (en) *	1994-11-16	1996-05-23	Sri International	COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY
US5785975A (en) *	1995-06-26	1998-07-28	Research Triangle Pharmaceuticals	Adjuvant compositions and vaccine formulations comprising same
US5770208A (en) *	1996-09-11	1998-06-23	Nabi	Staphylococcus aureus B-linked hexosamine antigen

1999
- 1999-09-14 ES ES99969030T patent/ES2321892T3/es not_active Expired - Lifetime
- 1999-09-14 AT AT99969030T patent/ATE421883T1/de active
- 1999-09-14 EP EP99969030A patent/EP1121135B1/en not_active Expired - Lifetime
- 1999-09-14 AU AU60332/99A patent/AU6033299A/en not_active Abandoned
- 1999-09-14 CA CA002344166A patent/CA2344166C/en not_active Expired - Fee Related
- 1999-09-14 PT PT99969030T patent/PT1121135E/pt unknown
- 1999-09-14 DE DE69940371T patent/DE69940371D1/de not_active Expired - Lifetime
- 1999-09-14 US US09/395,360 patent/US6355625B1/en not_active Expired - Lifetime
- 1999-09-14 DK DK99969030T patent/DK1121135T3/da active
- 1999-09-14 WO PCT/US1999/020787 patent/WO2000015238A1/en not_active Ceased
2009
- 2009-01-29 CY CY20091100108T patent/CY1109437T1/el unknown

Also Published As

Publication number	Publication date
ES2321892T3 (es)	2009-06-12
CA2344166A1 (en)	2000-03-23
EP1121135B1 (en)	2009-01-28
WO2000015238A9 (en)	2000-10-12
CY1109437T1 (el)	2014-08-13
WO2000015238B1 (en)	2000-08-31
US6355625B1 (en)	2002-03-12
ATE421883T1 (de)	2009-02-15
DE69940371D1 (de)	2009-03-19
CA2344166C (en)	2008-11-18
EP1121135A4 (en)	2005-03-16
EP1121135A1 (en)	2001-08-08
AU6033299A (en)	2000-04-03
WO2000015238A1 (en)	2000-03-23
PT1121135E (pt)	2009-03-05

Publication	Publication Date	Title
DK1121135T3 (da)	2009-03-23	Præparater af beta-glucaner og specifikke immunglobuliner
FR12C0004I2 (fr)	2013-01-11	Anticorps contre l'antigene ctla-4 humain et utilisation
BR9917152A (pt)	2002-11-26	Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos
ATE148130T1 (de)	1997-02-15	Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO971889L (no)	1997-06-23	Forbindelser og sammensetninger for levering av aktive midler
NO995349D0 (no)	1999-11-02	Multivalent vaksinasjonssammensetning med blandet baerer
BR0013771A (pt)	2002-05-14	Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
DK0951473T3 (da)	2002-09-16	Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
EA200000196A1 (ru)	2000-10-30	Универсальная плазма крови
TR200300478T2 (tr)	2004-10-21	Hümanize antiLT-ß-R antikorları
TR199900856T2 (xx)	1999-07-21	Bron�la ilgili terapi maddeleri olarak benzonaftiridinler
EP1171428A4 (en)	2004-09-15	FAB-I INHIBITORS
ES2009140A6 (es)	1989-09-01	Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.
YU68602A (sh)	2006-03-03	Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
ITMI950378A0 (it)	1995-02-28	Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono
ATE317263T1 (de)	2006-02-15	Diphosphonat derivate von therapeutisch wirksamen stoffen
LV12172A (lv)	1998-12-20	Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai
DK0633928T3 (da)	2004-03-22	Mikroorganismer, deres fremstilling og anvendelse
DE69928523D1 (de)	2005-12-29	Verotoxin b untereinheit zur immunisierunug
BR0016616A (pt)	2002-10-29	Microrganismos atenuados para o tratamento de infecção
TR199802452T2 (xx)	1999-02-22	Potasyum klavulanat�n preparasyonu i�in geli�tirilmi� bir proses.
BR0308734A (pt)	2005-01-11	Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
DK1159426T3 (da)	2006-05-15	Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner
EA200300388A1 (ru)	2003-08-28	1-аминоалкилциклогексаны в качестве трипаноцидных агентов
NO982151L (no)	1998-07-03	Hemoregulatoriske forbindelser